Preveceutical Med Inc New
(PRVCF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 43 | 1 | 4 | 13 | 117 |
| Receivables | 20 | 4 | 14 | 44 | 68 |
| TOTAL | $85 | $47 | $49 | $66 | $196 |
| Non-Current Assets | |||||
| PPE Net | 2 | 1 | 1 | 2 | 7 |
| Investments And Advances | 0 | 0 | 0 | 0 | 4 |
| Intangibles | 78 | 87 | 96 | 61 | 18 |
| TOTAL | $79 | $87 | $97 | $63 | $29 |
| Total Assets | $165 | $135 | $146 | $129 | $226 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,210 | 2,885 | 2,532 | 1,000 | 848 |
| Accounts payable and accrued liabilities | 1,753 | 1,530 | 1,179 | 1,066 | 667 |
| TOTAL | $4,962 | $4,415 | $3,711 | $2,066 | $1,515 |
| Non-Current Liabilities | |||||
| Long Term Debt | 46 | N/A | N/A | 48 | 45 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 1,290 | 1,356 |
| TOTAL | $46 | $N/A | $N/A | $1,338 | $1,401 |
| Total Liabilities | $5,008 | $4,415 | $3,711 | $3,403 | $2,916 |
| Shareholders' Equity | |||||
| Common Shares | 14,300 | 14,304 | 14,852 | 14,811 | 13,114 |
| Retained earnings | -21,573 | -21,046 | -20,968 | -22,761 | -20,095 |
| Other shareholders' equity | 2,430 | 2,461 | 2,551 | 4,676 | 4,290 |
| TOTAL | $-4,844 | $-4,281 | $-3,565 | $-3,275 | $-2,690 |
| Total Liabilities And Equity | $165 | $134 | $146 | $129 | $226 |